J Korean Neurol Assoc.  2016 Aug;34(3):167-175. 10.17340/jkna.2016.34.3.1.

Mild Cognitive Impairment

Affiliations
  • 1Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea. aelee@cnu.ac.kr

Abstract

Mild cognitive impairment (MCI) is an intermediate cognitive state between normal aging and dementia. It has disparate features in activities of daily life which is interfered notably in dementia. Recently, there have been consistent reports of MCI which is predementia, however significant controversy exist. In this review, we make out the diagnostic criteria, classification, risk factor, prevalence, diagnostic test including neuroimaging and biomarkers, management, and prognosis of MCI. This review will cover current knowledge and future directions on MCI.

Keyword

Mild cognitive impairment; Dementia; Biomarkers; Management

MeSH Terms

Aging
Biomarkers
Classification
Dementia
Diagnostic Tests, Routine
Mild Cognitive Impairment*
Neuroimaging
Prevalence
Prognosis
Risk Factors
Biomarkers
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr